申请人:A. Nattermann & Cie GmbH
公开号:US04504479A1
公开(公告)日:1985-03-12
The invention relates to new 6-5-[.omega.-(1-imidazolyl)-alkyl]-thien-2-yl}-3-oxo-2,3,4,5-tetrahydro-p yridazines having the general formula I ##STR1## and acid addition salts thereof and to a process for the treatment of inflammatory, atherosclerotic and thrombo-embolic diseases especially in humans.
该发明涉及具有一般式I的新6-5-[.omega.-(1-咪唑基)-烷基]-噻吩-2-基}-3-氧代-2,3,4,5-四氢-吡啶并其酸盐的制备方法,以及用于治疗炎症、动脉粥样硬化和血栓栓塞疾病,特别是在人类中的方法。